Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis.

Zhou YH, Tang JY, Wu MJ, Lu J, Wei X, Qin YY, Wang C, Xu JF, He J.

PLoS One. 2011;6(9):e25142. doi: 10.1371/journal.pone.0025142. Epub 2011 Sep 28. Review.

2.

Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials.

Ye Y, Li J, Yuan Z.

PLoS One. 2013;8(2):e56803. doi: 10.1371/journal.pone.0056803. Epub 2013 Feb 20.

3.

The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis.

Jardine MJ, Kang A, Zoungas S, Navaneethan SD, Ninomiya T, Nigwekar SU, Gallagher MP, Cass A, Strippoli G, Perkovic V.

BMJ. 2012 Jun 13;344:e3533. doi: 10.1136/bmj.e3533. Review.

4.

Effects of combined aspirin and clopidogrel therapy on cardiovascular outcomes: a systematic review and meta-analysis.

Zhou YH, Wei X, Lu J, Ye XF, Wu MJ, Xu JF, Qin YY, He J.

PLoS One. 2012;7(2):e31642. doi: 10.1371/journal.pone.0031642. Epub 2012 Feb 13.

5.

Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials.

Yang D, Li J, Yuan Z, Liu X.

PLoS One. 2013 May 8;8(5):e62329. doi: 10.1371/journal.pone.0062329. Print 2013.

6.

Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.

Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS.

JAMA. 2012 Sep 12;308(10):1024-33. doi: 10.1001/2012.jama.11374. Review.

PMID:
22968891
7.

Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.

Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL.

Eur J Intern Med. 2012 Dec;23(8):745-54. doi: 10.1016/j.ejim.2012.07.004. Epub 2012 Aug 11.

PMID:
22884409
8.

Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.

Kotwal S, Jun M, Sullivan D, Perkovic V, Neal B.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):808-18. doi: 10.1161/CIRCOUTCOMES.112.966168. Epub 2012 Oct 30. Review.

9.

Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.

Bazzano LA, Reynolds K, Holder KN, He J.

JAMA. 2006 Dec 13;296(22):2720-6. Erratum in: JAMA. 2007 Mar 7;297(9):952.

PMID:
17164458
10.

Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials.

Qin X, Huo Y, Xie D, Hou F, Xu X, Wang X.

Clin Nutr. 2013 Oct;32(5):722-7. doi: 10.1016/j.clnu.2012.12.009. Epub 2012 Dec 28.

PMID:
23313356
11.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

12.

Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.

Zhang X, Xiang C, Zhou YH, Jiang A, Qin YY, He J.

BMC Cardiovasc Disord. 2014 Feb 17;14:19. doi: 10.1186/1471-2261-14-19. Review.

13.

Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials.

Pan Y, Guo LL, Cai LL, Zhu XJ, Shu JL, Liu XL, Jin HM.

Br J Nutr. 2012 Aug;108(3):400-7. doi: 10.1017/S0007114511007033. Epub 2012 Jan 16. Review.

PMID:
22244447
14.

Association between B vitamins supplementation and risk of cardiovascular outcomes: a cumulative meta-analysis of randomized controlled trials.

Zhang C, Wang ZY, Qin YY, Yu FF, Zhou YH.

PLoS One. 2014 Sep 19;9(9):e107060. doi: 10.1371/journal.pone.0107060. eCollection 2014.

15.

Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis.

de Vries FM, Denig P, Pouwels KB, Postma MJ, Hak E.

Drugs. 2012 Dec 24;72(18):2365-73. doi: 10.2165/11638240-000000000-00000. Review.

PMID:
23186103
16.

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.

Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, Bønaa KH, Spence JD, Nygård O, Jamison R, Gaziano JM, Guarino P, Bennett D, Mir F, Peto R, Collins R; B-Vitamin Treatment Trialists' Collaboration.

Arch Intern Med. 2010 Oct 11;170(18):1622-31. doi: 10.1001/archinternmed.2010.348. Review.

PMID:
20937919
17.

Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels.

Miller ER 3rd, Juraschek S, Pastor-Barriuso R, Bazzano LA, Appel LJ, Guallar E.

Am J Cardiol. 2010 Aug 15;106(4):517-27. doi: 10.1016/j.amjcard.2010.03.064.

PMID:
20691310
18.

Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review.

Marik PE, Varon J.

Clin Cardiol. 2009 Jul;32(7):365-72. doi: 10.1002/clc.20604. Review.

19.

Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials.

Mao PJ, Zhang C, Tang L, Xian YQ, Li YS, Wang WD, Zhu XH, Qiu HL, He J, Zhou YH.

Int J Cardiol. 2013 Oct 30;169(2):106-11. doi: 10.1016/j.ijcard.2013.08.055. Epub 2013 Aug 27.

PMID:
24035175
20.

Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial.

Zoungas S, Lui M, Kerr PG, Teede HJ, McNeil JJ, McGrath BP, Polkinghorne KR.

Intern Med J. 2011 Dec;41(12):825-32. doi: 10.1111/j.1445-5994.2010.02226.x. Epub 2010 Mar 18.

PMID:
20298505
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk